Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Linking LDH-A, metastases and lactate identified by MRS imaging
    Meeting Abstract

    Serganova, I.; Rizwan, A.; Khanin, R.; Ni, X.; Karabeber, H.; Zakian, K.; Thakur, S.; Koutcher, J. A.; Blasberg, R.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Her2 expression in urothelial carcinoma with micropapillary morphology: Preferential overexpresssion by the micropapillary component
    Meeting Abstract

    Huang, H.; Jadallah, S.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Iyer, G. V.; Dalbagni, G.; Solit, D.; Reuter, V. E.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Her2 expression in urothelial carcinoma with micropapillary morphology: Preferential overexpresssion by the micropapillary component
    Meeting Abstract

    Huang, H.; Jadallah, S.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Iyer, G. V.; Dalbagni, G.; Solit, D.; Reuter, V. E.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Imaging abnormal metabolism in cancer: Association with an altered tumor microenvironment, immunological dysfunction and a propensity to develop metastases
    Meeting Abstract

    Blasberg, R.; Khanin, R.; Koutcher, J.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • E-cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • E-Cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: A retrospective analysis of pooled, prospective phase 2 trials
    Journal Article

    Sonpavde, G.; Pond, G. R.; Fougeray, R.; Choueiri, T. K.; Qu, A. Q.; Vaughn, D. J.; Niegisch, G.; Albers, P.; James, N. D.; Wong, Y. N.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
    Journal Article

    Morris, L. G. T.; Kaufman, A. M.; Gong, Y.; Ramaswami, D.; Walsh, L. A.; Turcan, S.; Eng, S.; Kannan, K.; Zou, Y.; Peng, L.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save